Revision of the American Joint Committee on Cancer staging system for breast cancer.
about
Inflammatory breast cancer: clinical progress and the main problems that must be addressedThe use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive studyPrognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialNF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationBone marrow micrometastases and circulating tumor cells: current aspects and future perspectives.Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerAdjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineAdjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineDual-Modality Photoacoustic and Ultrasound Imaging System for Noninvasive Sentinel Lymph Node Detection in Patients with Breast Cancer.Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineBiomarkers in cancer staging, prognosis and treatment selectionmiR-200b as a prognostic factor in breast cancer targets multiple members of RAB familyInfrequent loss of luminal differentiation in ductal breast cancer metastasisNew breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology imagesBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.Simultaneous inference of a misclassified outcome and competing risks failure time dataDetection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques.CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control studyShould we examine sentinel lymph nodes during the operation?Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancerMetastatic axillary node ratio predicts recurrence and poor long-term prognosis in patients with advanced stage IIIC (pN3) breast cancerIntegration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?Array-based DNA methylation profiling for breast cancer subtype discrimination.Trastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report.Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group.An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment.Breast cancer: Actual methods of treatment and future trends.Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.Bilateral chylothorax following left supraclavicular lymph node dissection for breast cancer: one case report and literature review.The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.Breast cancer care compared with clinical Guidelines: an observational study in France.Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancerDifferences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastasesCirculating tumor cells predict survival in early average-to-high risk breast cancer patients.
P2860
Q21195182-DA70CED8-2BFD-4ADC-9137-E6A907BD38F9Q21260415-DDF3BF19-5983-4B2C-930E-27489E79943AQ24597456-9AAFA79A-785E-46BC-9928-9C85CB62AFF0Q24653076-44F1DC20-A764-42E1-9013-E86BDEC10D35Q24796185-D010DB2E-4B3B-4EF2-8295-1C2445157A46Q24806218-2F163573-D4DE-4373-AA68-C6BDB28D4BAAQ26801108-47CEAEEC-68E0-46BB-B7FC-B5D54E90CBA0Q26853619-B977F03A-4A45-4D9C-8942-52734308EE27Q27002430-6755E4B6-AA8B-421C-9DA6-792D4877F01BQ27308066-DD879214-4100-421B-9FE5-078E57B8F99AQ28260063-875CC3DC-A2C0-4754-9A24-5186CCE6008BQ28278305-C3289C8C-4E96-4A80-B18A-F89A1CB425EAQ28394618-0A36D930-256F-4C19-81E9-705FF4AA107FQ28534555-6B034159-C242-4167-87F4-A3A7479FD39EQ28646873-086DFA88-2A32-48D4-AA04-D2DD94CDAD62Q30245184-E79A6AFB-B5A3-4838-83F4-A89C396055C5Q30416611-02DDAA05-DEEF-4D36-B1A9-5EBCF21729B3Q30569255-22C04DDF-BBE8-43B9-BD93-3AA8917A5F9CQ30915309-E968EF7A-EFA8-4198-904A-E6F79615EB45Q30919342-2DD78199-A9CD-4BB2-8506-C654E154940AQ33211966-496E050F-C3E2-4A1C-A7B4-43BA2F93E328Q33432351-3D67DFDE-00FB-4A33-9EFF-9E0DF6AB8957Q33601658-FC7A2BD1-762A-446B-9607-5AD7319BB2BFQ33630812-7A630F3C-5907-44E6-A359-A9C5ADB63578Q33636187-0E0CDFC4-D53E-446B-A352-84B728BD0671Q33670486-A953BD8B-4171-4703-87EF-E3620430972CQ33671525-034E6259-EA6B-45C5-A410-5673FF0FAF21Q33678314-30587BC5-9770-4213-9181-DDFFDD90CEDBQ33689442-5D41C32E-4939-438F-B010-908E383D78C8Q33727704-D6239F0F-74FE-4333-BEA7-D28939DBCE53Q33732403-DE3327CF-56C1-441B-8C55-C2B7F725622DQ33750517-71265A4A-05BA-4A66-8CD4-5C4111143E95Q33751802-E6B7FF4A-662D-4387-B072-EBCA0089B00AQ33762943-0D172550-AF41-45C8-8008-4CE9A22F5B36Q33764122-64D72861-672C-4B27-A047-0F037152C719Q33769034-1D9AC545-E030-4B66-B3DE-69191F02B10EQ33798676-B2036FAE-B15D-4738-B6CD-65F7C992D75FQ33942512-6565FB28-C565-4512-849F-67CA968AA023Q33954572-1CE4DA56-DB93-4C06-90E4-A00E0496D896Q33958981-C3D7E493-B720-461E-A91C-8FB23B710404
P2860
Revision of the American Joint Committee on Cancer staging system for breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Revision of the American Joint Committee on Cancer staging system for breast cancer.
@en
type
label
Revision of the American Joint Committee on Cancer staging system for breast cancer.
@en
prefLabel
Revision of the American Joint Committee on Cancer staging system for breast cancer.
@en
P2093
P356
P1476
Revision of the American Joint Committee on Cancer staging system for breast cancer.
@en
P2093
Abram Recht
Craig Allred
Daniel F Hayes
David L Page
Donald Berry
Donald L Weaver
Frederick L Greene
Gary Clark
H Samuel Wieand
P304
P356
10.1200/JCO.2002.02.026
P407
P577
2002-09-01T00:00:00Z